indazoles has been researched along with thymidine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galdieri, M | 1 |
| Adwankar, MK; Chitnis, MP | 1 |
| Bourgeois, Y; Bras Gonçalves, R; Dutrillaux, B; Miccoli, L; Oudard, S; Poirson-Bichat, F; Poupon, MF; Sureau, F | 1 |
| Kondapi, AK; Vashisht Gopal, YN | 1 |
| Ho, PY; Hsu, HK; Juan, SH; Lee, WS; Liang, YC; Lin, CH; Teng, CM | 1 |
| Chang, YL; Guh, JH; Kuo, SC; Lee, FY; Liu, YN; Pan, SL; Peng, CY; Teng, CM | 1 |
| Chang, JH; Chang, YL; Cheng, FC; Guh, JH; Kuo, SC; Lee, FY; Pan, SL; Peng, CY; Teng, CM; Wang, SW | 1 |
7 other study(ies) available for indazoles and thymidine
| Article | Year |
|---|---|
Lonidamine effect on male rat germ cells.
Topics: Animals; Antispermatogenic Agents; Cell Division; Cells, Cultured; Indazoles; Male; Pyrazoles; Rats; Rats, Inbred Strains; Spermatozoa; Thymidine | 1989 |
Modification of tumor cell sensitivity to antineoplastic agents lonidamine and bouvardin (NSC 259968) at elevated temperatures.
Topics: Animals; Antineoplastic Agents; DNA; Drug Resistance; Hyperthermia, Induced; Indazoles; Leukemia P388; Mice; Neoplasms, Experimental; Peptides, Cyclic; Pyrazoles; Sarcoma 180; Thymidine; Tritium | 1986 |
Potentiation of lonidamine and diazepam, two agents acting on mitochondria, in human glioblastoma treatment.
Topics: Animals; Anti-Anxiety Agents; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Division; Diazepam; Drug Synergism; Flow Cytometry; Fluorescence; Glioblastoma; Humans; Indazoles; Mice; Mice, Nude; Mitochondria; Thymidine; Treatment Outcome; Tumor Cells, Cultured | 1998 |
Topoisomerase II poisoning by indazole and imidazole complexes of ruthenium.
Topics: Adenosine Triphosphatases; Animals; Antineoplastic Agents; DNA; DNA Topoisomerases, Type II; Humans; Imidazoles; Indazoles; Molecular Structure; Nucleic Acid Conformation; Organometallic Compounds; Rats; Ruthenium Compounds; Thymidine; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 2001 |
YC-1 inhibits proliferation of human vascular endothelial cells through a cyclic GMP-independent pathway.
Topics: Cell Division; Cyclic GMP; DNA; Endothelium, Vascular; G1 Phase; Humans; Indazoles; Platelet Aggregation Inhibitors; Resting Phase, Cell Cycle; Thymidine; Tritium | 2003 |
The indazole derivative YD-3 inhibits thrombin-induced vascular smooth muscle cell proliferation and attenuates intimal thickening after balloon injury.
Topics: Administration, Oral; Animals; Aorta, Thoracic; Arteriosclerosis; Blotting, Western; Catheterization; Cell Proliferation; Cells, Cultured; Coronary Restenosis; Dose-Response Relationship, Drug; Flavonoids; Immunohistochemistry; Indazoles; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Models, Chemical; Muscle, Smooth, Vascular; Peptides; Phosphorylation; Protein Kinase Inhibitors; ras Proteins; Rats; Rats, Wistar; Receptor, PAR-1; Signal Transduction; Thrombin; Thymidine | 2004 |
YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models.
Topics: Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Blotting, Western; Cell Movement; Cell Proliferation; Endothelial Cells; Endothelium, Vascular; Enzyme Activators; Extracellular Signal-Regulated MAP Kinases; Fibroblast Growth Factor 2; Guanylate Cyclase; Humans; Indazoles; Longevity; Microtubules; Neoplasms; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Protein Kinase C; Signal Transduction; Tetrazolium Salts; Thiazoles; Thymidine; Vascular Endothelial Growth Factor A | 2005 |